Citation Impact
Citing Papers
Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy
2017
Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol
2012
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
Metal–organic framework-based materials: superior adsorbents for the capture of toxic and radioactive metal ions
2018 Standout
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Beta adrenergic blockade and decompensated cirrhosis
2016
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Prevention of variceal rebleeding
2003
Forces in Tissue Morphogenesis and Patterning
2013 Standout
Endoscopic Variceal Ligation plus Propranolol versus Endoscopic Variceal Ligation Alone in Primary Prophylaxis of Variceal Bleeding
2005
Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension
2009
Now there are many (stages) where before there was one
2009
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis
2005
Burden of liver diseases in the world
2018 Standout
The Hemodynamic Response to Medical Treatment of Portal Hypertension As A Predictor of Clinical Effectiveness in the Primary Prophylaxis of Variceal Bleeding in Cirrhosis
2000
Serum albumin and platelet count but not portal pressure are predictive of death in patients with Child-Pugh A hepatitis C virus-related cirrhosis
2005
Acute Hemodynamic Response to β-Blockers and Prediction of Long-term Outcome in Primary Prophylaxis of Variceal Bleeding
2009
Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: What is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
2007
Detection ofRickettsia,Borrelia, andBartonellainCarios kelleyi(Acari: Argasidae)
2005
BMP9 Mutations Cause a Vascular-Anomaly Syndrome with Phenotypic Overlap with Hereditary Hemorrhagic Telangiectasia
2013
Bed Bugs (<emph type="ital">Cimex lectularius</emph>) and Clinical Consequences of Their Bites
2009 Standout
Optogenetic control of heart muscle in vitro and in vivo
2010
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Far-red to near infrared analyte-responsive fluorescent probes based on organic fluorophore platforms for fluorescence imaging
2012 Standout
Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
2013
Value of the Hepatic Venous Pressure Gradient to Monitor Drug Therapy for Portal Hypertension: A Meta-Analysis
2007
Impaired PIEZO1 function in patients with a novel autosomal recessive congenital lymphatic dysplasia
2015 StandoutNobel
Pharmacological Reduction of Portal Pressure and Long-Term Risk of First Variceal Bleeding in Patients with Cirrhosis
2006
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis
2007
Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: A 10-year prospective study
1996
Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: A multicentre randomized controlled trial
2013
Expanding consensus in portal hypertension
2015 Standout
Vascular disorders of the liver # †
2008 Standout
Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments
2015
Lack of prognostic usefulness of hepatic venous pressures and hemodynamic values in a select group of patients with severe alcoholic cirrhosis
2002
Portal hypertension and variceal bleeding—Unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference
2008
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis
2007
Portal hypertensive bleeding in cirrhosis
2016 Standout
Improved clinical outcome using polytetrafluoroethylene-coated stents for tips: Results of a randomized study
2004
Mechanisms of Hepatic Fibrogenesis
2008 Standout
19F Magnetic Resonance Imaging (MRI): From Design of Materials to Clinical Applications
2014
Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis
1991
Microfluidic organs-on-chips
2014 Standout
Somatostatin Treatment and Risk Stratification by Continuous Portal Pressure Monitoring During Acute Variceal Bleeding
2001
The Effects of Hemodynamic Force on Embryonic Development
2010
Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding
2004
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Liver stiffness measurement predicts severe portal hypertension in patients with HCV‐related cirrhosis†‡
2007
Global burden of liver disease: 2023 update
2023 Standout
Squaraine Rotaxanes: Superior Substitutes for Cy‐5 in Molecular Probes for Near‐Infrared Fluorescence Cell Imaging
2007
Review article: the modern management of portal hypertension – primary and secondary prophylaxis of variceal bleeding in cirrhotic patients
2008
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2000
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Novel inflammatory biomarkers of portal pressure in compensated cirrhosis patients
2013
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices
1992
QUANTIFYING PARASITES IN SAMPLES OF HOSTS
2000 Standout
Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings
1998
Prognostic value of early measurements of portal pressure in acute variceal bleeding
1999
Optogenetics in Neural Systems
2011 Standout
Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding
1994
Effects of the removal of large herbivores on fleas of small mammals
2008
Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension
2010 Standout
Fluid Dynamics of Heart Development
2011
Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis
2007
Continuous prazosin administration in cirrhotic patients: Effects on portal hemodynamics and on liver and renal function
1995
The treatment of portal hypertension: A meta-analytic review
1995
The hepatic venous pressure gradient: Anything worth doing should be done right
2004
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Recombinant protein (EGFP-Protein G)-coated PbS quantum dots forin vitroandin vivodual fluorescence (visible and second-NIR) imaging of breast tumors
2014
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Compound Copper Chalcogenide Nanocrystals
2017
The Development and Application of Optogenetics
2011 Standout
Fluid flows and forces in development: functions, features and biophysical principles
2012
Integrating Person‐Centered and Variable‐Centered Analyses: Growth Mixture Modeling With Latent Trajectory Classes
2000 Standout
Mechanobiology and Developmental Control
2013
“Draining the Sea”: Mass Killing and Guerrilla Warfare
2004 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Zr-based metal–organic frameworks: design, synthesis, structure, and applications
2016 Standout
Systematic review with meta‐analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis
2014
Biology of the Bed Bugs (Cimicidae)
2006
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Species Richness of Parasite Assemblages: Evolution and Patterns
1997 Standout
Piezo1, a mechanically activated ion channel, is required for vascular development in mice
2014 StandoutNobel
Recent advances in organic thermally activated delayed fluorescence materials
2017 Standout
The Posttraumatic Stress Disorder Checklist for DSM‐5 (PCL‐5): Development and Initial Psychometric Evaluation
2015 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Parasitology Meets Ecology on Its Own Terms: Margolis et al. Revisited
1997 Standout
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Portal Hypertension and Its Complications
2008
Recent Development of Chemosensors Based on Cyanine Platforms
2016
Hemodynamic Response to Pharmacological Treatment of Portal Hypertension and Long–Term Prognosis of Cirrhosis
2003
Defaunation in the Anthropocene
2014 StandoutScience
Hepatic Vein Pressure Gradient Reduction and Prevention of Variceal Bleeding in Cirrhosis: A Systematic Review
2006
No Lessons Learned from the Holocaust? Assessing Risks of Genocide and Political Mass Murder since 1955
2003 Standout
Development of hyperdynamic circulation and response to β‐blockers in compensated cirrhosis with portal hypertension
2015
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis
2021
Update on Tick-Borne Rickettsioses around the World: a Geographic Approach
2013 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Nanoscale Metal–Organic Frameworks for Real-Time Intracellular pH Sensing in Live Cells
2014
Near-infrared fluorophores for biomedical imaging
2017 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Democracy and the Violation of Human Rights: A Statistical Analysis from 1976 to 1996
2004 Standout
Ultrahigh 19F Loaded Cu1.75S Nanoprobes for Simultaneous 19F Magnetic Resonance Imaging and Photothermal Therapy
2016
Works of Michael J. Patrick being referenced
Properties of New, Long-Wavelength, Voltage-sensitive Dyes in the Heart
2005
BIOTIC AND ABIOTIC EFFECTS ON ENDOPARASITES INFECTINGDIPODOMYSANDPEROGNATHUSSPECIES
2001
Aortic Arch Morphogenesis and Flow Modeling in the Chick Embryo
2009
Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage
1990
Fleas on Gray Foxes in New Mexico
1995
Two-color fluorescent (near-infrared and visible) triphasic perfluorocarbon nanoemulsions
2013
Ectoparasite Associations of Bats from Central Pennsylvania
2003
Interaction between alk1 and blood flow in the development of arteriovenous malformations
2011
Distribution of Enteric Helminths in Glaucomys Volans L. (Sciurdiae): A Test for Competition
1991
Short–Term Effects of Propranolol on Portal Venous Pressure
1986
Intracellular pH Measurements Using Perfluorocarbon Nanoemulsions
2013